{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:00:18Z","timestamp":1771509618759,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1080\/14653240600620176","type":"journal-article","created":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T17:37:43Z","timestamp":1146245863000},"page":"105-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma"],"prefix":"10.1016","volume":"8","author":[{"given":"L.J.N.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ausubel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Shakeley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.V.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.L.","family":"Digiusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1080\/14653240600620176_bib0005","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nrc1167","article-title":"Adoptive-cell-transfer therapy for the treatment of patients with cancer","volume":"3","author":"Dudley","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1080\/14653240600620176_bib0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14653240310001028","article-title":"Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy","volume":"5","author":"Jensen","year":"2003","journal-title":"Cytotherapy"},{"key":"10.1080\/14653240600620176_bib0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bcmd.2004.03.003","article-title":"Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies","volume":"33","author":"Cooper","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"10.1080\/14653240600620176_bib0020","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/jgm.489","article-title":"Genetic engineering of cytolytic T lymphocytes for adoptive T-cell therapy of neuroblastoma","volume":"6","author":"Gonzalez","year":"2004","journal-title":"J Gene Med"},{"key":"10.1080\/14653240600620176_bib0025","doi-asserted-by":"crossref","first-page":"9160","DOI":"10.1158\/0008-5472.CAN-04-0454","article-title":"Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells","volume":"64","author":"Kahlon","year":"2004","journal-title":"Cancer Res"},{"key":"10.1080\/14653240600620176_bib0030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0921-4410(04)22014-2","article-title":"T-cell genetic modification for re-directed tumor recognition","volume":"22","author":"Cooper","year":"2005","journal-title":"Cancer Chemother Biol Response Modifiers"},{"key":"10.1080\/14653240600620176_bib0035","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2002-07-1989","article-title":"T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect","volume":"101","author":"Cooper","year":"2003","journal-title":"Blood"},{"key":"10.1080\/14653240600620176_bib0040","series-title":"Molecular Cloning","author":"Sambrook","year":"2001"},{"key":"10.1080\/14653240600620176_bib0045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1034\/j.1399-0039.1999.530202.x","article-title":"Rapid screening of T-cell receptor (TCR) variable gene usage by multiplex PCR: application for assessment of clonal composition","volume":"53","author":"Akatsuka","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1080\/14653240600620176_bib0050","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/cyto.990090617","article-title":"Modified histogram subtraction technique for analysis of flow cytometry data","volume":"9","author":"Overton","year":"1988","journal-title":"Cytometry"},{"key":"10.1080\/14653240600620176_bib0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0008-8749(84)90080-7","article-title":"Monoclonal antibody against K562 cell line accelerates killing of the target cells by large granular lymphocytes","volume":"84","author":"Park","year":"1984","journal-title":"Cell Immunol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532490670857X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532490670857X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:09:56Z","timestamp":1761430196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146532490670857X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"alternative-id":["S146532490670857X"],"URL":"https:\/\/doi.org\/10.1080\/14653240600620176","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/14653240600620176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}